Knowledge and Attitudes about Human Papillomaviruses and Immunization among Turkish Pediatricians

  • Ozsurekci, Yasemin (Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine) ;
  • Oncel, Eda Karadag (Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine) ;
  • Bayhan, Cihangul (Department of Pediatrics, Hacettepe University Faculty of Medicine) ;
  • Celik, Melda (Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine) ;
  • Ozkaya-Parlakay, Aslinur (Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine) ;
  • Arvas, Mehmet (Gynecologic Oncology Division, American Hospital) ;
  • Ceyhan, Mehmet (Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine)
  • Published : 2013.12.31


Background: Human papillomavirus (HPV) is one of the most common sexually transmitted infectious agents, and the effectiveness of vaccine delivery programs will depend largely upon whether providers recommend vaccines. The objectives of this study were to examine pediatrician characteristics, knowledge, and attitudes associated with HPV and HPV immunization. Materials and Methods: Attendees of the national pediatric meeting in 2011, were asked to complete a questionnaire that, aside from demographic information, elicited level of agreement with statements regarding HPV, its related diseases, and HPV vaccination. It also documented attitudes and beliefs about HPV vaccination. Results: Of the 480 attendees, 226 (47%) filled in the questionnaire. The level of pediatrician HPV-related knowledge varied. The majority (78%) were aware that HPV infection is the most common sexually transmitted infection, while 51% were unaware that a condom is ineffective protection against HPV infection. Between 60-80% of respondents were aware of the effectiveness of HPV vaccination for women. On the other hand, only 10% were aware of reasons why men should be vaccinated against HPV. The majority (75%) of Turkish pediatricians were likely to recommend HPV vaccination to their daughter, if they had one. Seventy percent of pediatricians agreed that the HPV vaccination should be added to the National Immunization Program (NIP) in Turkey. However, the respondents documented concerns about the cost of the vaccination. Conclusions: Increasing pediatricians' knowledge and awareness of HPV and HPV vaccination may assist with the implementation of an effective NIP.


  1. Alsaad MA, Shamsuddin K, Fadzil F (2012). Knowledge towards HPV infection and HPV vaccines among Syrian Mothers. Asian Pac J Cancer Prev, 13, 879-83.
  2. Clifford GM, Gallus S, Herrero R, et al (2005). Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet, 366, 991-8.
  3. Daley MF, Liddon N, Crane LA, et al (2006). A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics, 118, 2280-9.
  4. Demir ET, Ceyhan M, Simsek M, et al (2012). The prevalence of different HPV types in Turkish women with a normal Pap smear. J Med Virol, 84, 1242-7.
  5. Dempsey AF, Zimet GD, Davis RL, et al (2006). Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics, 117, 1486-93.
  6. Dursun P, Senger SS, Arslan H, Kuscu E, Ayhan A (2009). Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis, 9, 191.
  7. Harper DM, Franco EL, Wheeler C, et al (2004). Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet, 364, 1757-65.
  8. Harper DM, Franco EL, Wheeler CM, et al (2006). Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet, 367, 1247-55.
  9. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD (1998). Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med, 338, 423-8.
  10. Jaspers L, Budiningsih S, Wolterbeek R, et al (2011). Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia:A cross-sectional study. Vaccine, 29, 7785-93.
  11. Ilter E, Celik A, Haliloglu B, et al (2010). Women's knowledge of pap smear test and human papillomavirus. Int J Gynecol Cancer, 20, 1058-62.
  12. Inal MM, Kose S, Yildirim Y, et al (2007). The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. Int J Gynecol Cancer, 17, 1266-70.
  13. International Agency for Research on Cancer (IARC). (2007). Summary of data reported and evaluations: IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: World Health Organization, 90, 465-77.
  14. Ishibashi KL, Koopmans J, Curlin FA, Alexander KA, Ross LF (2008). Pediatricians are more supportive of the human papillomavirus vaccine than the general public. South Med J, 101, 1216-21.
  15. Kahn JA, Rosenthal SL, Tissot AM, et al (2007). Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr, 7, 367-73.
  16. Kahn JA, Zimet GD, Bernstein DI, et al (2005). Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health, 37, 502-10.
  17. Mao C, Koutsky LA, Ault KA, et al (2006). Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol, 107, 18-27.
  18. Markowitz LE, Dunne EF, Saraiya M, et al (2007). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 56, 1-24.
  19. Marlow LAV, Waller J, Wardle J (2007). Parental attitudes to pre-pubertal HPV vaccination. Vaccine, 25, 1945-52.
  20. Munoz N, Bosch FX, de Sanjose S, et al (2003). International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.
  21. Olshen E, Woods ER, Austin SB, et al (2005). Parental acceptance of the human papillomavirus vaccine. J Adolesc Med, 37, 248-51.
  22. Ortashi O, Raheel H, Shalal M, et al (2013). Awareness and knowledge about human papillomavirus infection and vaccination among women in UAE. Asian Pac J Cancer Prev, 14, 6077-80.
  23. Ozcelik B, Serin IS, Gokahmetoglu S, Basbug M, Erez R (2003). Human papillomavirus frequency of women at low risk of developing cervical cancer: a preliminary study from a Turkish university hospital. Eur J Gynaecol Oncol, 24, 157-9.
  24. American Academy of Pediatrics ((2012)). Human Papillomaviruses. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book, Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2012:[524-30]
  25. Rand CM, Shone LP, Albertin C, et al (2007). National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med, 161, 252-9.
  26. Riedesel JM, Rosenthal SL, Zimet GD, et al (2005). Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol, 18, 391-8.
  27. Trottier H, Franco EL (2006). The epidemiology of genital human papillomavirus infection. Vaccine, 24, 1-15.
  28. Tuncer ZS, Boyraz G, Sahin N, Alp A (2012). Distribution of human papillomavirus types in Turkish women. Eur J Gynaecol Oncol, 33, 204-6.
  29. Vadaparampil ST, Kahn JA, Salmon D, et al (2011). Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine, 29, 8634-41.
  30. Villa LL, Costa RL, Petta CA, et al (2005). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol, 6, 271-8.
  31. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.<12::AID-PATH431>3.0.CO;2-F
  32. Winer RL, Feng Q, Hughes JP, et al (2008). Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis, 197, 279-82.
  33. Winer RL, Lee SK, Hughes JP, et al (2003). Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol, 157, 218-26.
  34. Wong LP (2009). Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups. J Low Genit Tract Dis, 13, 85-93.
  35. Woo YL, Razali SM, Chong KR, et al (2012). Does the success of a school-based HPV vaccine programme dependon teachers' knowledge and religion?- a survey in a multicultural society. Asian Pac J Cancer Prev, 13, 4651-54.
  36. Woodman CB, Collins S, Winter H, et al (2001). Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet, 357, 1831-6.
  37. Zimet GD, Mays RM, Fortenberry JD (2000). Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control. Sex Transm Dis, 27, 49-52.
  38. Ziv A, Boulet JR, Slap GB (1999). Utilization of physician offices by adolescents in the United States. Pediatrics, 104, 35-42.

Cited by

  1. Knowledge, Attitudes and Beliefs about Cervical Cancer and Human Papilloma Virus Vaccination with Related Factors in Turkish University Students vol.15, pp.8, 2014,
  2. Awareness and Attitude Relating to the Human Papilloma Virus and its Vaccines Among Pediatrics, Obstetrics and Gynecology Specialists in Turkey vol.15, pp.24, 2015,
  3. A Survey of Wisconsin Pediatricians’ Knowledge and Practices Regarding the Human Papillomavirus Vaccine vol.156, pp.4, 2017,
  4. Knowledge and attitudes of women regarding gynaecological cancer prevention in an urban area of Greece in financial crisis vol.31, pp.4, 2017,